| Product Name | MF | CAS | Details |
|---|
| Pseudolaric Acid C | C21H26O7 | 82601-41-0 | Details |
| 1-(4-Bromophenyl)-2-methyl-1H-imidazole-5-carbaldehyde | C11H9BrN2O | 1002107-33-6 | Details |
| Polygodial pyridazine | C15H22N2 | 1810726-08-9 | Details |
| 1-(2',3'-Difluorophenyl)-2-nitroethene | C8H5F2NO2 | 934625-92-0 | Details |
| Amitriptyline antibody | Details |
| 4,5-Dimethoxy-2-methylbenzaldehyde | C10H12O3 | 7721-62-2 | Details |
| MIB1 antibody (FITC) | Details |
| ML289 | C22H23NO3 | 1382481-79-9 | Details |
| Hepcidin-22 (human) trifluoroacetate salt | C99H151N29O25S9 | 342790-22-1 | Details |
| Progesterone | C21H30O2 | Details |
| Methyl 3-oxocyclohexanecarboxylate | C8H12O3 | 13148-83-9 | Details |
| Tetrakis(4-carboxyphenyl)silane | C28H20O8Si | 10256-84-5 | Details |
| Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside | C7H12Cl2O4 | 4990-82-3 | Details |
| 5-bromo-2-(propan-2-yloxy)aniline | C9H12BrNO | 1019442-22-8 | Details |
| 1-(4-Ethylphenyl)-3-methylbutan-1-one | C13H18O | 137128-80-4 | Details |
| 4-{8-Oxa-3-azabicyclo[3.2.1]octan-3-yl}aniline | C12H16N2O | 1416369-78-2 | Details |
| 2,2',3,4,4',5-Hexachlorobiphenyl | C12H4Cl6 | 35694-06-5 | Details |
| Methyl 5-(chlorosulfonyl)pyridine-3-carboxylate | C7H6ClNO4S | 594839-14-2 | Details |
| 1-(2-Bromophenyl)-2-(methylamino)ethan-1-ol | C9H12BrNO | 1498728-16-7 | Details |
| H-GLHVMHKVAPPRGGGC-OH | Details |
| 1-(1H-Imidazol-2-yl)ethan-1-one hydrochloride | C5H7ClN2O | 1955506-52-1 | Details |
| 3-(1-Methyl-1H-pyrazol-4-yl)-isoxazole-5-carboxylic acid | C8H7N3O3 | 957312-81-1 | Details |
| LCBiot-KRKLIVDSVKELDSKTIRAQLSDYS-OH | Details |
| 4-Hydroxy-pyridine-2-carboxylic acid methylamide | C7H8N2O2 | 611226-36-9 | Details |
| Dimethyl 1,3-Dithiole-2-thione-4,5-dicarboxylate | C7H6O4S3 | 7396-41-0 | Details |
| RAC1 antibody | Details |
| CSTF2 Blocking Peptide | Details |
| 6-Bromopteridin-4(3H)-one | C6H3BrN4O | 1192150-15-4 | Details |
| 1-{4-[2-(5-Methylfuran-2-yl)quinoline-4-carbonyl]piperazin-1-yl}ethan-1-one | C21H21N3O3 | 1031195-19-3 | Details |
| 2-((tert-butyl)sulfonyl)-3-(4-hydroxyphenyl)prop-2-enenitrile | C13H15NO3S | 1025704-84-0 | Details |
| Ethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-thioglucopyranoside | C16H25NO8S | 49810-41-5 | Details |
| 4-Methoxy Propranolol | C17H23NO3 | 18507-09-0 | Details |
| Ac-CETVFHRVSQDGLDL-NH2 | Details |
| (1R,2R)-1-Fluoro-2-phenylcyclopropane-1-carboxylic acid | C10H9FO2 | 1932192-07-8 | Details |
| (Glu9)-Exenatide (2-39) trifluoroacetate salt | 196109-34-9 | Details |
| H-DGLILTSR-OH | Details |
| Methyl 2-amino-3-chloro-5-fluorobenzoate | C8H7ClFNO2 | 1184351-57-2 | Details |
| Methyl 3-(cyclopropylamino)-2-methylpropanoate | C8H15NO2 | 1154152-89-2 | Details |
| 7-Amino-3-methyl-1,2-dihydroquinolin-2-one | C10H10N2O | 124954-81-0 | Details |
| 3,3-Dimethyl-1-(3-pyridinyl)-1-butanamine | C11H18N2 | 959239-41-9 | Details |
| 2-{[1-(2,4-Difluorophenyl)ethyl]amino}-N-ethylacetamide | C12H16F2N2O | 1155464-60-0 | Details |
| N-(3-Hydroxyphenyl)thiophene-2-carboxamide | C11H9NO2S | 307525-91-3 | Details |
| KHDRBS1 antibody | Details |
| Bis-(1,3-diethylthiobarbituric acid)trimethine oxonol | C19H24N4O4S2 | 47623-98-3 | Details |
| 3-Deoxygalactosone | C6H10O5 | 4134-97-8 | Details |
| Erysubin B | C20H16O6 | 221150-19-2 | Details |
| H-EVGDWRK^-OH | Details |
| 1-(3,4-Dihydro-2H-1-benzopyran-6-yl)propan-1-one | C12H14O2 | 70452-02-7 | Details |
| Dynorphin A (1-7) | C40H61N13O9 | 77101-32-7 | Details |
| 1-(Trifluoromethyl)cyclohexane-1-carbonitrile | C8H10F3N | 1638519-58-0 | Details |
| 2-Benzoyl-3-phenylaziridine | C15H13NO | 51659-21-3 | Details |
| ANXA11 protein (His tag) | Details |
| Z-Phe-Tyr(tBu)-diazomethylketone | C31H34N4O5 | 114014-15-2 | Details |
| RAB39B protein (His tag) | Details |
| beta Amylase antibody | Details |
| 1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-2-(propan-2-yl)pyrrolidine-3-carboxylic acid | C23H25NO4 | 2137686-87-2 | Details |
| 3-Sulfanyl-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid | C7H5N3O2S | 1208249-77-7 | Details |
| GDF15 antibody | Details |
| Nimotuzumab | 828933-51-3 | Details |
| N-[1-(2-Chloroacetyl)piperidin-4-yl]-3-phenylpropanamide | C16H21ClN2O2 | 1306603-07-5 | Details |
| 3-(1-Ethyl-3-methyl-1H-pyrazol-4-yl)propanoic acid | C9H14N2O2 | 956371-97-4 | Details |
| 2-(1,2,3,4-Tetrahydroisoquinolin-2-yl)acetonitrile | C11H12N2 | 91349-97-2 | Details |
| 4-(9-Oxo-9,10-dihydroacridin-10-yl)butanoic acid | C17H15NO3 | 90053-07-9 | Details |
| N,1-Dimethyl-1H-indole-2-carboxamide | C11H12N2O | 61939-18-2 | Details |
| 3,3-Dimethyl-1-(2,2,2-trifluoroethyl)piperazine | C8H15F3N2 | 1432678-44-8 | Details |
| Methyl 1-bromocycloheptane-1-carboxylate | C9H15BrO2 | 1065573-86-5 | Details |
| Lesopitron dihydrochloride | C15H22Cl2N6 | 132449-89-9 | Details |
| 2-[(Carbamoylmethyl)amino]benzamide | C9H11N3O2 | 941203-88-9 | Details |
| (2R)-2-Amino-4-phenoxybutanoic acid hydrochloride | C10H14ClNO3 | 2031242-33-6 | Details |
| Crystallin Zeta Blocking Peptide | Details |
| 3-(Chloromethyl)-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole hydrochloride | C6H9Cl2N3 | 1820685-05-9 | Details |
| CD164 antibody | Details |
| N-butyl-1-phenylcyclopentane-1-carboxamide | C16H23NO | 354992-72-6 | Details |
| 2,3-Dimethylindoline | C10H13N | 22120-50-9 | Details |
| 5-Amino-1-(2-fluorophenyl)-N'-hydroxy-1H-pyrazole-4-carboximidamide | C10H10FN5O | 89433-80-7 | Details |
| 2-Methyl-3-(phenylsulfanyl)propanoic acid | C10H12O2S | 775-20-2 | Details |
| 2-(Methylsulfanyl)butanoic acid | C5H10O2S | 874525-90-3 | Details |
| 1-(4-Bromophenyl)-1,1-difluoropropan-2-one | C9H7BrF2O | 897934-99-5 | Details |
| 2-(1-Ethyl-1H-1,3-benzodiazol-2-yl)ethan-1-amine dihydrochloride | C11H17Cl2N3 | 1258640-90-2 | Details |
| 3-(Chloromethyl)-4,5-dimethyl-4H-1,2,4-triazole hydrochloride | C5H9Cl2N3 | 1034197-53-9 | Details |
| TMEM135 Blocking Peptide | Details |
| 4H,5H,6H,7H-Pyrazolo[1,5-a]pyrimidine-3-carboxamide | C7H10N4O | 115931-34-5 | Details |
| N-Palmitoyl(d9) D-erythro-sphingosine | C34H67NO3 | 2260669-51-8 | Details |
| Dimethyl(1,2,3,4-tetrahydroquinolin-2-ylmethyl)amine | C12H18N2 | 1701-48-0 | Details |
| (3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl)-N-(3-(phenylmethoxy)phenyl)formamide | C24H18ClFN2O3 | 889781-87-7 | Details |
| 5-(4-Methylpiperazin-1-yl)isoquinolin-8-amine | C14H18N4 | 1155134-93-2 | Details |
| 2-(1-Chloroethyl)-5-(3,4-dimethylphenyl)-1,3,4-oxadiazole | C12H13ClN2O | 1156945-18-4 | Details |
| PTTG1IP antibody | Details |
| 6-Bromo-1H-1,3-benzodiazole-5-carbonitrile | C8H4BrN3 | 294192-25-9 | Details |
| PGM5 antibody | Details |
| 1-(4-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-(4-acetamido)phenyl acetate | C27H23ClN2O5 | 68483-33-0 | Details |
| iminosugar 2 | Details |
| 3-(Pyridin-2-yloxy)phenol | C11H9NO2 | 66982-42-1 | Details |
| (1H-Benzoimidazol-5-yl)carbamic acid tert-butyl ester | C12H15N3O2 | 885270-97-3 | Details |
| 6-Hydroxy-3,3-dimethyl-2,3-dihydro-1H-inden-1-one | C11H12O2 | 166978-00-3 | Details |
| 3-(Trifluoromethyl)-1H-pyrazol-4-amine | C4H4F3N3 | 1248452-50-7 | Details |
| 6-Bromo-3,4-dihydrospiro[1,4-benzoxazine-2,1'-cyclopropane] | C10H10BrNO | 1291094-46-6 | Details |
| Biot-EDPDYEWPSA-NH2 | Details |
| 1,2,3,4-Tetrahydropyridin-4-one | C5H7NO | 24681-60-5 | Details |
| N-Methyl-2-(4-methylphenoxy)-1-ethanamine | C10H15NO | 625437-29-8 | Details |
| Product Total： Product Page： | ||||
| 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 | ||||